Literature DB >> 14720328

Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation.

Atsushi Kaneda1, Tetsuya Tsukamoto, Takeji Takamura-Enya, Naoko Watanabe, Michio Kaminishi, Takashi Sugimura, Masae Tatematsu, Toshikazu Ushijima.   

Abstract

Hypomethylation of the global genome, considered to be composed mainly of repetitive sequences, is consistently observed in cancers, and aberrant hypo- and hypermethylation of CpG islands (CGIs) in promoter regions are also observed. Since methylation alterations in unique promoter sequences and in other genomic regions have distinct consequences, we analyzed the relationship between the global hypomethylation and the hypomethylation of unique promoter CGIs using human gastric cancers. Seven of ten gastric cancer cell lines showed marked decreases in 5-methylcytosine content, which correlated with hypomethylation of the LINE1 repetitive sequence. Six of the seven cell lines showed hypomethylation in five or all of the six normally methylated CGIs in promoter regions of six genes, and this was associated with induction of aberrant expression. The remaining three cell lines without global hypomethylation showed promoter hypomethylation in one or none of the six CGIs. Frequent promoter hypomethylation, however, did not correlate with frequent promoter hypermethylation. In primary gastric cancers too, global hypomethylation was associated with hypomethylation of LINE1 repetitive sequence and promoter hypomethylation. Of 93 gastric cancers, 33 cancers with frequent promoter hypomethylation and 27 cancers with frequent promoter hypermethylation constituted different groups. These findings represent experimental evidence that frequent hypomethylation of normally methylated promoter CGIs is associated with global hypomethylation, and that these hypomethylations occur independently of frequent promoter CGI hypermethylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720328     DOI: 10.1111/j.1349-7006.2004.tb03171.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  23 in total

1.  Implications of LINE1 methylation for bladder cancer risk in women.

Authors:  Charlotte S Wilhelm; Karl T Kelsey; Rondi Butler; Silvia Plaza; Luc Gagne; M Scot Zens; Angeline S Andrew; Steven Morris; Heather H Nelson; Alan R Schned; Margaret R Karagas; Carmen J Marsit
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

2.  Global hypomethylation of genomic DNA in cancer-associated myofibroblasts.

Authors:  Le Jiang; Tamas A Gonda; Mary V Gamble; Martha Salas; Venkatraman Seshan; Shuiping Tu; William S Twaddell; Peter Hegyi; Gyorgy Lazar; Islay Steele; Andrea Varro; Timothy C Wang; Benjamin Tycko
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  DNA methylation: a marker for carcinogen exposure and cancer risk.

Authors:  Takeshi Nakajima; Shotaro Enomoto; Toshikazu Ushijima
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

4.  DNA Methylation and Flavonoids in Genitourinary Cancers.

Authors:  Neelam Mukherjee; Addanki P Kumar; Rita Ghosh
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

Review 5.  Epigenetic effects of ethanol on liver and gastrointestinal injury.

Authors:  Shivendra D Shukla; Annayya R Aroor
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

6.  Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.

Authors:  Anna Woloszynska-Read; Wa Zhang; Jihnhee Yu; Petra A Link; Paulette Mhawech-Fauceglia; Golda Collamat; Stacey N Akers; Kelly R Ostler; Lucy A Godley; Kunle Odunsi; Adam R Karpf
Journal:  Clin Cancer Res       Date:  2011-02-04       Impact factor: 12.531

7.  Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.

Authors:  M Ehrlich; C B Woods; M C Yu; L Dubeau; F Yang; M Campan; D J Weisenberger; Ti Long; B Youn; E S Fiala; P W Laird
Journal:  Oncogene       Date:  2006-04-27       Impact factor: 9.867

8.  Relationship between the extent of chromosomal losses and the pattern of CpG methylation in gastric carcinomas.

Authors:  Seung-Jin Hong; Young-Ho Kim; Young-Deok Choi; Ki-Ouk Min; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

9.  A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory.

Authors:  Akiko Murayama; Kazuhisa Sakura; Mina Nakama; Kayoko Yasuzawa-Tanaka; Etsuko Fujita; Yukiyo Tateishi; Yinan Wang; Toshikazu Ushijima; Tadashi Baba; Kazuko Shibuya; Akira Shibuya; Yoh-ichi Kawabe; Junn Yanagisawa
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

10.  Mechanisms of peroxisome proliferator-induced DNA hypomethylation in rat liver.

Authors:  Igor P Pogribny; Volodymyr P Tryndyak; Anna Boureiko; Stepan Melnyk; Tetyana V Bagnyukova; Beverly Montgomery; Ivan Rusyn
Journal:  Mutat Res       Date:  2008-07-01       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.